Filing Details
- Accession Number:
- 0001144204-18-062413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-29 19:00:27
- Reporting Period:
- 2018-11-27
- Accepted Time:
- 2018-11-29 19:00:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1270073 | Intercept Pharmaceuticals Inc. | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1493811 | Christian Weyer | C/O Intercept Pharmaceuticals, Inc. 10 Hudson Yards, Floor 37 New York NY 10001 | Evp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-11-27 | 1,438 | $108.66 | 17,162 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-11-29 | 1,343 | $113.78 | 15,819 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock.
- This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.